StockNews.com Initiates Coverage on Athersys (NASDAQ:ATHX)
Investment analysts at StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX – Get Free Report) in a research note issued on Saturday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Athersys Price Performance Athersys has a 52 week low of $0.01 and a 52 week high of $1.99. The company has a […]
Investment analysts at StockNews.com began coverage on shares of Athersys (NASDAQ:ATHX – Get Free Report) in a research note issued on Saturday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Athersys Price Performance Athersys has a 52 week low of $0.01 and a 52 week high of $1.99. The company has a […]
